GB201617726D0 - Medicament and assay - Google Patents

Medicament and assay

Info

Publication number
GB201617726D0
GB201617726D0 GBGB1617726.3A GB201617726A GB201617726D0 GB 201617726 D0 GB201617726 D0 GB 201617726D0 GB 201617726 A GB201617726 A GB 201617726A GB 201617726 D0 GB201617726 D0 GB 201617726D0
Authority
GB
United Kingdom
Prior art keywords
medicament
assay
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1617726.3A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Queens University of Belfast
Original Assignee
Queens University of Belfast
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Queens University of Belfast filed Critical Queens University of Belfast
Priority to GBGB1617726.3A priority Critical patent/GB201617726D0/en
Publication of GB201617726D0 publication Critical patent/GB201617726D0/en
Priority to US16/343,266 priority patent/US11376308B2/en
Priority to PCT/GB2017/053157 priority patent/WO2018073591A1/en
Priority to EP17790816.7A priority patent/EP3528831B1/en
Priority to US17/828,969 priority patent/US20220347264A1/en
Ceased legal-status Critical Current

Links

GBGB1617726.3A 2016-10-19 2016-10-19 Medicament and assay Ceased GB201617726D0 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
GBGB1617726.3A GB201617726D0 (en) 2016-10-19 2016-10-19 Medicament and assay
US16/343,266 US11376308B2 (en) 2016-10-19 2017-10-18 Use of FKBP-L polypeptides and nucleic acids for the treatment of obesity
PCT/GB2017/053157 WO2018073591A1 (en) 2016-10-19 2017-10-18 Use of fkbp-l polypeptides and nucleic acids for the treatment of obesity
EP17790816.7A EP3528831B1 (en) 2016-10-19 2017-10-18 Use of fkbp-l polypeptides and nucleic acids for the treatment of obesity
US17/828,969 US20220347264A1 (en) 2016-10-19 2022-05-31 Use of fkbp-l polypeptides and nucleic acids for the treatment of obesity

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1617726.3A GB201617726D0 (en) 2016-10-19 2016-10-19 Medicament and assay

Publications (1)

Publication Number Publication Date
GB201617726D0 true GB201617726D0 (en) 2016-11-30

Family

ID=57680830

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1617726.3A Ceased GB201617726D0 (en) 2016-10-19 2016-10-19 Medicament and assay

Country Status (1)

Country Link
GB (1) GB201617726D0 (en)

Similar Documents

Publication Publication Date Title
HK1243741A1 (en) Tnfrsf-binding agents and uses thereof
IL255577B (en) Tigit-binding agents and uses thereof
HK1249103B (en) Polycyclic-carbamoylpyridone compounds and their pharmaceutical use
EP3302442A4 (en) Dosage forms and use thereof
IL264813B (en) 2-oxo-imidazopyridines and their use
HK1252026A1 (en) Pharmaceutical combination and uses thereof
HK1247091A1 (en) Therapeutic antibodies and uses thereof
HUE048503T2 (en) Dihydropyrimidine-2-one compounds and medicinal uses thereof
TWI563001B (en) Disintegrin variants and pharmaceutical uses thereof
IL254241A0 (en) Etv2 and uses thereof
GB201404372D0 (en) Assay and treatment
IL264473A (en) Gpr156 variants and uses thereof
IL265531A (en) N 3 -cyclically substituted thienouraciles and use thereof
GB201418809D0 (en) Therapeutic agents and uses thereof
PL3094338T3 (en) Assay and medicament
GB201508028D0 (en) Sandfalls and the like
GB201617761D0 (en) Medicament and assay
GB201617726D0 (en) Medicament and assay
GB201715421D0 (en) Assays and medical uses
GB2545167B (en) Cloches and use thereof
AU2015902260A0 (en) Pharmaceutical Combination and Uses Thereof
GB201419354D0 (en) Pharmaceutical extracts and uses thereof
AU2014901186A0 (en) Therapeutic Agents and Uses Thereof

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)